MCEMP1

Across TCGA pan-cancer cohorts, MCEMP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated MCEMP1 data layer compared with 27 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MCEMP1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MCEMP1 expression acts as an unfavorable survival marker, although some lineages such as GBM and LSCC show a favorable association.

LUAD, UCEC, and GBM are the cancer types where MCEMP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.821	0.994	.008	16	view →
UCEC	DFS	Tertile	All	0.572	1.000	.019	10	view →
GBM	DFS	Median	All	0.620	0.135	.036	2	view →
LSCC	OS	Quartile	All	0.928	0.764	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MCEMP1–LUAD (DFS)

Open the LUAD breakdown →